Thread
:
Prothena Phase 1B study of Alpha Synuclein and Parkinsons! Yeah!
View Single Post
03-10-2017, 07:20 PM
jeffreyn
Member
Join Date: Apr 2016
Location: Australia
Posts: 352
jeffreyn
Member
Join Date: Apr 2016
Location: Australia
Posts: 352
Some background information
For those who might have missed it, the results from the preceding Single Ascending Dose (SAD) trial were published late last year:
First-in-human assessment of PRX 2, an anti–α-synuclein monoclonal antibody, in healthy volunteers - Schenk - 2 16 - Movement Disorders - Wiley Online Library
(this is an open-access document)
and here is the trial record for the recently-completed Multiple Ascending Dose (MAD) trial:
Multiple Ascending Dose Study of PRX 2 in Patients With Parkinson's Disease - Full Text View - ClinicalTrials.gov
Reply With Quote
"Thanks for this!" says:
anagirl
(03-11-2017)
jeffreyn
View Public Profile
Find More Posts by jeffreyn
jeffreyn
View Public Profile
Find More Posts by jeffreyn